Q1 2026 Holdings
Filed 2026-05-15 | 39 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $188.1M | 8,050,959 | 11.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $185.3M | 5,840,567 | 11.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $169.8M | 2,922,335 | 10.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $155.4M | 4,037,331 | 9.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $136.7M | 3,398,224 | 8.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $87.7M | 3,682,185 | 5.4% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $70.6M | 15,013,093 | 4.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $54.1M | 5,680,795 | 3.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $46.6M | 1,569,018 | 2.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $45.8M | 2,341,652 | 2.8% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $44.3M | 3,114,132 | 2.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $40.4M | 2,247,393 | 2.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $36.7M | 1,820,954 | 2.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $33.2M | 825,000 | 2.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $28.5M | 1,576,295 | 1.8% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $27.9M | 934,799 | 1.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $26.7M | 884,937 | 1.6% |
| Travere Therapeutics Inc(TVTX)Call | COM | 89422G107 | $23.8M | 800,000 | 1.5% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $21.7M | 872,558 | 1.3% |
| Revolution Medicines Inc(RVMD)Put | COM | 76155X100 | $20.2M | 207,500 | 1.2% |
| Burning Rock Biotech LTD(BNR) | SPONSORED ADS | 12233L206 | $19.8M | 1,227,555 | 1.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $18.7M | 560,000 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $18.5M | 1,194,757 | 1.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $18.1M | 640,395 | 1.1% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $14.4M | 625,496 | 0.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $14.2M | 1,424,259 | 0.9% |
| Geron Corp(GERN) | COM | 374163103 | $10.2M | 6,836,318 | 0.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $9.2M | 1,356,843 | 0.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $8.3M | 784,606 | 0.5% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $7.0M | 965,193 | 0.4% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $6.9M | 1,003,341 | 0.4% |
| Amarin Corp PLC(EH3) | SPONSORED ADR | 023111404 | $6.8M | 472,382 | 0.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.9M | 702,884 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $5.4M | 1,592,551 | 0.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $4.8M | 2,503,302 | 0.3% |
| Alector Inc(ALEC) | COM | 014442107 | $4.3M | 2,000,000 | 0.3% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $2.5M | 1,566,317 | 0.2% |
| Travere Therapeutics Inc(TVTX)Put | COM | 89422G107 | $1.6M | 54,900 | 0.1% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $980.0K | 200,000 | 0.1% |